Tryptic Shaving of Staphylococcus aureus Unveils Immunodominant Epitopes on the Bacterial Cell Surface

Annette Dreisbach1, Min Wang1, Magdalena M van der Kooi-Pol1

  • 1Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P. O. Box 30001, 9700 RB Groningen, the Netherlands.

Insights

Developing new immunization strategies against Staphylococcus aureus is crucial due to rising antibiotic resistance. This study identified key surface proteins as potential targets for effective anti-staphylococcal vaccines.

Area of Science:

  • Microbiology
  • Immunology
  • Proteomics

Background:

  • Staphylococcus aureus is an opportunistic pathogen causing significant health threats due to antibiotic resistance and rapid spread.
  • Existing anti-staphylococcal immunization strategies are lacking for clinical use, necessitating new approaches.
  • Acute phase infections require effective prevention and treatment strategies.

Purpose of the Study:

  • To identify novel targets for active or passive immunization against Staphylococcus aureus.
  • To profile the cell-surface-exposed proteome of Staphylococcus aureus under infection-mimicking conditions.
  • To discover immunodominant, surface-exposed epitopes for vaccine development.

Main Methods:

  • Utilized "bacterial shaving" with immobilized or soluble trypsin followed by mass spectrometry.
  • Analyzed non-covalently cell-wall-bound proteins and exoproteome via gel-free proteomics.
  • Screened cell-wall-attached proteins for immunoglobulin G binding from patients with chronic S. aureus infections.

Main Results:

  • Identified specific cell-surface-exposed Staphylococcus aureus proteins.
  • Highlighted proteins with highly immunogenic exposed epitopes.
  • Data available via ProteomeXchange accession PXD000156.

Conclusions:

  • Certain cell-surface-exposed Staphylococcus aureus proteins are promising targets for developing protective immunization strategies.
  • These findings pave the way for new anti-staphylococcal vaccines.
  • Further research can focus on these identified immunogenic targets.